Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: no known allergies / adverse drug reactions attending: chief complaint: gi bleeding pancreatic mass major surgical or invasive procedure: : successful embolization of a ruptured 4-mm gda aneurysm, with four cook coils. . : ercp . : ercp history of present illness: 59f with history of substance abuse, transferred to with hematochezia and a ct showing ruptured gda artery aneurysm. patient presented with 1 week history of epigastric pain, 24h of hematochezia, hypotension, tachycardia. ct here showing ruptured gda artery aneurysm with hematoma compressing the cbd s/p ir embolization on a superior gda aneurysm . she received 8 units prbc, 4 unit ffp, 1 platelet for her procedure. post-procedure, patient had rising lfts and bili. had ercp done showing a 1.5 cm single irregular stricture at the lower third of the cbd and possible malignant infiltration on the duodenum. covered biliary stent was placed. ca -9 6489 and cea 63. post .ercp lipase 1097 and tbili still rising to 12.3. past medical history: pmh: manic depression, substance abuse (cocaine, heroin), history of dts social history: substance abuse family history: unknown physical exam: on admission: vitals: t 98.9 hr 96 bp 156/76 rr 18 so2 99/ra gen: a&ox3, nad heent: no scleral icterus, mucus membranes moist cv: rrr, no m/g/r pulm: clear to auscultation b/l, no w/r/r abd: soft, mildly distended, tender in epigastrium, no rebound or guarding, normoactive bowel sounds, no palpable masses ext: no le edema, le warm and well perfused upon discharge: vss. afebrile gen: somewhat confused, nad cv: rrr pulm: ctab abd: soft, tender in epigastric area extr: warm, no c/c/e pertinent results: 03:53am blood wbc-4.5 rbc-4.45 hgb-13.3 hct-39.4 mcv-89 mch-29.8 mchc-33.6 rdw-15.1 plt ct-100* 03:53am blood glucose-204* urean-5* creat-0.5 na-142 k-3.6 cl-107 hco3-27 angap-12 08:29am blood alt-52* ast-63* ld(ldh)-200 alkphos-74 totbili-3.8* 03:53am blood calcium-9.4 phos-3.2 mg-1.5* pathology examination name birthdate age sex pathology # , 59 female report to: dr. /dr. /dr. gross description by: dr. , la,/mtd specimen submitted: gi biopsy (1 jar). procedure date tissue received report date diagnosed by dr. /mrr?????? diagnosis: duodenum: adenocarcinoma, moderately differentiated; reviewed by dr. . brown. cta abd: impression: 1. new interval perisplenic and perihepatic hemoperitoneum. 2. interval coiling of known gastroduodenal artery aneurysm with decreased peri-aneurysmal fluid and decreased fluid within the duodenum. no definite mass identified. normal pancreatic duct. 3. findings consistent with cirrhosis and portal hypertension including nodular heterogeneous liver, splenomegaly, varices and upper abdominal lymphadenopathy. 4. interval placement of wall stent within the cbd, with expected pneumobilia. cta abd: impression: 1. no evidence of persistent filling of this patient's previously embolized pancreaticoduodenal artery aneurysm. no evidence of active or recent further bleeding identified. 2. ill-defined mass in the region of pancreatic head, abutting but not occluding the duodenum, and encasing the hepatic artery and attenuating the splenic vein with secondary signs of splenic venous hypertension. 3. small amount of perihepatic fluid and free fluid within the pelvis, none suggesting acute or subacute hemorrhage. 4. multiple chronic changes including cholelithiasis, simple periumbilical hernia, atherosclerotic disease, renal cysts. brief hospital course: 59f transferred from osh with a 1 week history of epigastric pain, 24h of bloody stools, hypotension, tachycardia. a cta was obtained on admission, and demonstrated a ruptured superior gda artery aneurysm with hematoma compressing the cbd. she was taken to ir for embolization, hct was 26. she received 8 units prbc, 4 unit ffp, 1 platelet for her procedure. she was subsequently admitted to ticu s/p ir embolization of gda. extubated without event that evening, and her foley was removed. ms. was placed on ciwa/ ativan for withdrawal symptoms and dilaudid for pain. on , ms. was found to be hemodynamically stable, with 5 serial stable hematocrits, and she was advanced to a regular diet. her total bilirubin rose to 6.6, but alk phos was unchanged. her respiratory status was monitored, and she was comfortable on room air. she was deemed stable for transfer to the surgical floor. 0n : patient underwent ercp, single irregular stricture of malignant appearance that was 1.5 cm long was seen at the lower third of the common bile duct, cytology and pathology were sent, and a 60mm by 10fr wallflex fully covered biliary stent was placed successfully in the main duct. the patient's cea was 63, ca -9 6489. : the cytology came back negative for malignant cells. pathology was positive for adenocarcinoma. : patient had increased abdominal pain, her amylase and lipase were elevated. the patient was made npo, antibiotics were started for ercp induced pancreatitis. : patient's amylase and lipase improving, diet was advanced to sips. : patient had blood bowel movement. she was transferred to the icu, received 2 units of rbc and serial hct was followed. her hct was stable and she was transferred back to the floor. ercp revealed bleeding from duodenal mass, epinephrine injections were applied for hemostasis. there was ongoing oozing of blood after epinephrine injection. : hct was stable. patient was transitioned to oral dilaudid for pain control with iv breakthrough. : the patient was seen by radiology/oncology and referred to hospital radiology/oncology to discuss radiation treatment. the patient will also follow up with med/onc in gsh. hct was stable. : discharged home in stable condition. knowing patient's substance abuse history, she underwent extensive teaching about appropriate use of narcotics pain medication prior discharge. the patient verbalized understanding, she will follow up with her pcp to discuss needs to restart treatment with suboxone. medications on admission: suboxone 36 tablets 2.5 daily q 15 days gabapentin 800 mg tid; glipizide xl 10mg once daily simvastatin 20mg one tablety daily abilify 30mg daily in am discharge medications: 1. aripiprazole 30 mg po daily 2. docusate sodium 100 mg po bid rx *docusate sodium 100 mg 1 capsule(s) by mouth twice a day disp #*60 capsule refills:*0 3. gabapentin 300 mg po tid 4. glipizide xl 10 mg po daily 5. pantoprazole 40 mg po q24h rx *pantoprazole 40 mg 1 tablet(s) by mouth once a day disp #*30 tablet refills:*2 6. senna 1 tab po bid:prn constipation 7. oxycodone (immediate release) 5-15 mg po q4h:prn pain rx *oxycodone 5 mg tablet(s) by mouth every four (4) hours disp #*90 tablet refills:*0 discharge disposition: home discharge diagnosis: 1. gastroduodenal artery aneurysm 2. locally advanced pancreatic adenocarcinoma discharge condition: mental status: confused - sometimes. level of consciousness: alert and interactive. activity status: ambulatory - independent. discharge instructions: please call your doctor or nurse practitioner if you experience the following: *you experience new chest pain, pressure, squeezing or tightness. *new or worsening cough, shortness of breath, or wheeze. *if you are vomiting and cannot keep down fluids or your medications. *you are getting dehydrated due to continued vomiting, diarrhea, or other reasons. signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *you see blood or dark/black material when you vomit or have a bowel movement. *you experience burning when you urinate, have blood in your urine, or experience a discharge. *your pain is not improving within 8-12 hours or is not gone within 24 hours. call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *you have shaking chills, or fever greater than 101.5 degrees fahrenheit or 38 degrees celsius. *any change in your symptoms, or any new symptoms that concern you. followup instructions: department: surgical specialties when: friday at 1:15 pm with: , md building: sc clinical ctr campus: east best parking: garage . please follow up with dr. (pcp) on at 18:00 . hospital radiology/oncology department. dr. on at 10:00 . procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours insertion of endotracheal tube endoscopic sphincterotomy and papillotomy endoscopic control of gastric or duodenal bleeding endoscopic insertion of stent (tube) into bile duct transcatheter embolization for gastric or duodenal bleeding closed [endoscopic] biopsy of small intestine other closed [endoscopic] biopsy of biliary duct or sphincter of oddi diagnoses: pure hypercholesterolemia tobacco use disorder unspecified essential hypertension cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension other, mixed, or unspecified drug abuse, unspecified unspecified viral hepatitis c without hepatic coma anxiety state, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypotension, unspecified malignant neoplasm of head of pancreas obstruction of bile duct bipolar disorder, unspecified drug withdrawal delirium due to conditions classified elsewhere acute pancreatitis hemoperitoneum (nontraumatic) aneurysm of other visceral artery secondary malignant neoplasm of small intestine including duodenum other digestive system complications other nonspecific abnormal finding of lung field 

Answer: The patient is high likely exposed to